Landos Biopharma, Inc. (LABP) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 2 Buy, 4 Hold, 1 Sell.
LABP Analyst Ratings
Hold
7
Ratings
2 Buy
4 Hold
1 Sell
Based on 7 analysts giving stock ratings to Landos Biopharma, Inc. in the past 3 months
